199 related articles for article (PubMed ID: 32168417)
41. Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for Pain.
Zhi WI; Ingram E; Li SQ; Chen P; Piulson L; Bao T
Integr Cancer Ther; 2018 Dec; 17(4):1079-1086. PubMed ID: 30027756
[TBL] [Abstract][Full Text] [Related]
42. Acupuncture May Help to Prevent Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Sham-Controlled, Single-Blind Study.
Huang MC; Chang SC; Liao WL; Ke TW; Lee AL; Wang HM; Chang CP; Yen HR; Chang HH; Chen WT
Oncologist; 2023 Jun; 28(6):e436-e447. PubMed ID: 36971468
[TBL] [Abstract][Full Text] [Related]
43. New diagnostic measures of oxaliplatin-induced peripheral sensory neuropathy.
Szpejewska JE; Yilmaz M; Falkmer UG; Arendt-Nielsen L; Mørch CD
Cancer Treat Res Commun; 2022; 31():100543. PubMed ID: 35255440
[TBL] [Abstract][Full Text] [Related]
44. Neurotoxicity Outcomes in a Population-based Cohort of Elderly Patients Treated With Adjuvant Oxaliplatin for Colorectal Cancer.
Raphael MJ; Fischer HD; Fung K; Austin PC; Anderson GM; Booth CM; Singh S
Clin Colorectal Cancer; 2017 Dec; 16(4):397-404.e1. PubMed ID: 28434884
[TBL] [Abstract][Full Text] [Related]
45. Non-randomized preliminary study of an education and elastic-band resistance exercise program on severity of neuropathy, physical function, muscle strength and endurance & quality of life in colorectal cancer patients experiencing oxaliplatin-induced peripheral neuropathy.
Chen SC; Huang HP; Huang WS; Lin YC; Chu TP; Beaton RD; Jane SW
Eur J Oncol Nurs; 2020 Dec; 49():101834. PubMed ID: 33120223
[TBL] [Abstract][Full Text] [Related]
46. A Randomized Sham-Controlled Mixed Methods Pilot Study of the Feasibility of Acupuncture for Chemotherapy-Induced Neuropathy: Lessons Learned From Patient Experiences in Integrative Cancer Care.
Lagerstedt K; Efverman A
Integr Cancer Ther; 2023; 22():15347354231178877. PubMed ID: 37294052
[TBL] [Abstract][Full Text] [Related]
47. Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study.
Jongeneel G; Greuter MJE; van Erning FN; Twisk JWR; Koopman M; Punt CJA; Vink GR; Coupé VMH
Int J Cancer; 2021 Jun; 148(11):2702-2711. PubMed ID: 33460468
[TBL] [Abstract][Full Text] [Related]
48. Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.
Cao Y; Chang Q; Zhang W; Ornatsky O; Hedley D; Chen EX
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1195-1200. PubMed ID: 31520102
[TBL] [Abstract][Full Text] [Related]
49. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
[TBL] [Abstract][Full Text] [Related]
50. Incidence, severity, longitudinal trends and predictors of acute and chronic oxaliplatin-induced peripheral neuropathy in Taiwanese patients with colorectal cancer.
Hsu SY; Huang WS; Lee SH; Chu TP; Lin YC; Lu CH; Beaton RD; Jane SW
Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12976. PubMed ID: 30536809
[TBL] [Abstract][Full Text] [Related]
51. Traditional Chinese Medicine syndrome analysis on oxaliplatin-induced peripheral neuropathy and clinical efficacy of Bushen Yiqi formula: a prospective randomized controlled study.
Longci P; Chunhui QI; Xubo S; Yixian H; Xinrong Y; Xianjun S
J Tradit Chin Med; 2023 Oct; 43(6):1234-1242. PubMed ID: 37946486
[TBL] [Abstract][Full Text] [Related]
52. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
53. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study.
Attal N; Bouhassira D; Gautron M; Vaillant JN; Mitry E; Lepère C; Rougier P; Guirimand F
Pain; 2009 Aug; 144(3):245-252. PubMed ID: 19457614
[TBL] [Abstract][Full Text] [Related]
54. A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy.
Kotaka M; Saito Y; Kato T; Satake H; Makiyama A; Tsuji Y; Shinozaki K; Fujiwara T; Mizushima T; Harihara Y; Nagata N; Kurihara N; Ando M; Kusakawa G; Sakai T; Uchida Y; Takamoto M; Kimoto S; Hyodo I
Cancer Chemother Pharmacol; 2020 Nov; 86(5):607-618. PubMed ID: 32965539
[TBL] [Abstract][Full Text] [Related]
55. Repetitive Acupuncture Point Treatment with Diluted Bee Venom Relieves Mechanical Allodynia and Restores Intraepidermal Nerve Fiber Loss in Oxaliplatin-Induced Neuropathic Mice.
Yeo JH; Yoon SY; Kwon SK; Kim SJ; Lee JH; Beitz AJ; Roh DH
J Pain; 2016 Mar; 17(3):298-309. PubMed ID: 26604098
[TBL] [Abstract][Full Text] [Related]
56. Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
Gu Z; Wei G; Zhu L; Zhu L; Hu J; Li Q; Cai G; Lu H; Liu M; Chen C; Ji Y; Li G; Huo J
Evid Based Complement Alternat Med; 2021; 2021():5551568. PubMed ID: 34630609
[No Abstract] [Full Text] [Related]
57. Acupuncture and integrative oncology for taxane-induced peripheral neuropathy: a randomized multicentered study.
Ben-Arye E; Gamus D; Samuels N; Schiff E; Hausner D; Gressel O; Attias S; Lavie O; David A; Shulman K; Agbarya A
Int J Gynecol Cancer; 2023 May; 33(5):792-801. PubMed ID: 36600535
[TBL] [Abstract][Full Text] [Related]
58. Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment.
Kang L; Tian Y; Xu S; Chen H
J Neurol; 2021 Sep; 268(9):3269-3282. PubMed ID: 32474658
[TBL] [Abstract][Full Text] [Related]
59. Acupuncture and PC6 stimulation for the prevention of postoperative nausea and vomiting in patients undergoing elective laparoscopic resection of colorectal cancer: a study protocol for a three-arm randomised pilot trial.
Kim KH; Kim DH; Bae JM; Son GM; Kim KH; Hong SP; Yang GY; Kim HY
BMJ Open; 2017 Jan; 7(1):e013457. PubMed ID: 28052910
[TBL] [Abstract][Full Text] [Related]
60. [Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study].
Eckel F; Schmelz R; Adelsberger H; Erdmann J; Quasthoff S; Lersch C
Dtsch Med Wochenschr; 2002 Jan; 127(3):78-82. PubMed ID: 11797144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
